The objectives of development should be integrated into drug policies, particularly in developing countries. Crop eradication should not be carried out unless alternative livelihoods and the infrastructure on which they depend have been put in place first. In addition, the effectiveness of drug policies must be gauged against developmental and human security criteria.
As NPS have entered the markets at an unprecedented rate, legislation has been unable to keep pace. This report for policymakers and legal practioners, from the EMCDDA and Eurojust, aims to outline the challenges and paths forward in NPS regulation.
Prison reform under the MAS government confronts serious hurdles but has demonstrated a commitment to confront institutional problems in the judiciary, police, and prison systems through varied initiatives.
Through testimonies of former and current drug addicts, social workers, health workers and policy makers, this short film highlights what harm reduction means and how it works within the Senegalese context.
Transform release the second edition of their guide to regulating legal markets for the non-medical use of cannabis. It is for policy makers, drug policy reform advocates and affected communities all over the world.
The voices of affected communities involved in the cultivation of prohibited plants are lacking in the global debate on drug policy reform in general and were at risk of being excluded from the UNGASS 2016. This report presents the discussions at the GFPPP.
How can the outcomes of international drug control policy be measured? Currently, the UN drug control system lacks appropriate metrics to do so. However, the adoption of the Sustainable Development Goals offers a chance to find new – and potentially better – answers to this question.